Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 10/20 | 0.45 |
| ▸ | HCRTR2 | O43614 | 10/20 | 0.45 |
| ▸ | MMP1 | P03956 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31473148 | 0.83 | BRD4 (0.33) | HCRTR1HCRTR2PDE10A | |
| SCHEMBL31473150 | 0.82 | HDAC1 (0.40) | KDM4EALDH1A1 | |
| SCHEMBL31473158 | 0.79 | EHMT2 (0.40) | MMP1MMP9MMP3 | |
| SCHEMBL31473144 | 0.79 | HCRTR1 (0.43) | HCRTR1HCRTR2KDM4E | |
| SCHEMBL31473167 | 0.76 | MAPT (0.38) | KDM4EALDH1A1 | |
| SCHEMBL31473141 | 0.69 | CAPN1 (0.35) | ALDH1A1 | |
| SCHEMBL13314537 | 0.66 | CYSLTR1 (0.57) | PDE10A | |
| SCHEMBL31473155 | 0.65 | FSHR (0.31) | — | |
| SCHEMBL31473156 | 0.62 | LMNA (0.37) | KDM4EALDH1A1 | |
| SCHEMBL31473157 | 0.62 | CYP2C9 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119403810-A | Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseases | 瓦斯塞拉股份有限公司 | 2025-02-07 | — | — | CN | disclosed |